A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
The Johns Hopkins University hit biotechnology company Life Technologies with an infringement suit in North Carolina federal court, accusing the company of ripping off the school’s patented gene sequencing technology. Law360